Halozyme Therapeutics | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amarin USD -21529000 24.42M 2024-09
Amgen USD 3.38B 111M 2024-12
Baxter International USD -289000000 594M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
DBV Technologies EUR -30442000 2.67M 2024-09
Eli Lilly USD 5.54B 3.83B 2024-12
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Intra Cellular Therapies USD -17202000 8.75M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
MannKind USD 8.44M 834K 2024-12
Pfizer USD 4.44B 2.36B 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12



Halozyme Therapeutics Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.